Medpace Holdings, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for MEDP, updated each market day.
MEDP AI Sentiment
AI sees no strong directional signal for Medpace Holdings, Inc. Common Stock stock over the next 10 market days.
Prediction date: May 20, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Medpace Holdings, Inc. Common Stock
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Sector
Exchange
Market Cap
$11,971,364,838
Cap Tier
Employees
6,300
Headquarters
CINCINNATI, OH
Listed Since
Aug. 11, 2016
Website
MEDP Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MEDP Volatility
Medpace Holdings, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
